Trials / Completed
CompletedNCT05432258
Nano-Hybrid vs Bulk-Fill Resin Composites
Evaluation of the Nano-Hybrid and Bulk-Fill Resin Composites: Randomised Controlled Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Izmir Katip Celebi University · Academic / Other
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to compare the 2-year clinical performance of bulk-fill composites, which can be applied as a single layer, and the nano-hybrid filled composite resins, which are frequently used in clinical routine, in children in a split-mouth design. This study was conducted on 89 patients aged 6-12 years who had caries on bilateral mandibular first molars. Our study has a randomized, cross-controlled, and double-blind design. In split-mouth design, restorations of mandibular permanent molars completed with nano-hybrid ORMOCER based bulk-fill filling material Admira Fusion x-tra (Voco GmbH, Cuxhaven, Germany) and nano-hybrid composite Grandio (Voco , Cuxhaven, Germany). Futurabond U single dose (Voco, Cuxhaven, Germany) universal adhesive was used for all restorations, in the selective enamel etching mode. The clinical success of the restorations will be evaluated at 6, 12 and 24-month controls. Evaluations has been made by two physicians other than the one who did the restoration, who do not know which restorative material was applied to which tooth.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bulk-fill composite resin | Restoration of the mandibular first molars with bulk-fill composite resin as the manufacturer advises after the cavity preparation |
| DEVICE | Nano-fill composite resin | Restoration of the mandibular first molars with nano-fill composite resin as the manufacturer advises after the cavity preparation |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2022-07-26
- Completion
- 2022-07-26
- First posted
- 2022-06-27
- Last updated
- 2023-10-02
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05432258. Inclusion in this directory is not an endorsement.